Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

53.12
Delayed Data
As of Feb 05
 -3.64 / -6.41%
Today’s Change
45.45
Today|||52-Week Range
71.60
-10.33%
Year-to-Date

Today’s Trading

Previous close56.76
Today’s open56.25
Day’s range52.62 - 56.34
Volume13,263,242
Average volume (3 months)9,922,216
Market cap$86.8B
Dividend yield4.29%
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+184.55%
Earnings growth (this year)+17.01%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+14.52%
P/E ratio30.7
Price/Sales4.24
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.04+0.05%
CELGCelgene-4.04-3.96%
AZNAstraZeneca-0.44-1.44%
NVONovo Nordisk-0.75-1.51%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateApril 22, 2016
EPS forecast (this quarter)$1.13
Annual revenue (last year)$22.9B
Annual profit (last year)$5.1B
Net profit margin22.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts

Partner Offers